Evidence map›Paper›PMID 30968311›Full record

ReviewDermatology and therapy2019

Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis.

Susana Puig, Corinne Granger, Aurora Garre, Carles Trullàs, Onofre Sanmartin, Giuseppe Argenziano

Open access · goldAbstract readReview
In one paragraph

Review in Dermatology and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Photolyase Production and Current Applications: A Review.Molecules (Basel, Switzerland) · 2022
    Review
  9. [Sunscreens of the future: challenges and opportunities].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Use of a Topical Film-Forming Medical Device Containing RepairsomesClinical, cosmetic and investigational dermatology · 2020
    Article
  17. Six critical questions for DNA repair enzymes in skincare products: a review in dialog.Clinical, cosmetic and investigational dermatology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Susana PuigDermatology Department, Melanoma Unit, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. spuig@clinic.cat.
Corinne GrangerInnovation and Development, ISDIN, Barcelona, Spain.
Aurora GarreInnovation and Development, ISDIN, Barcelona, Spain.
Carles TrullàsInnovation and Development, ISDIN, Barcelona, Spain.
Onofre SanmartinDepartment of Dermatology, Fundación Instituto Valenciano de Oncologia, Universidad Católica de Valencia San Vicente Martir, Valencia, Spain.
Giuseppe ArgenzianoDermatology Unit, Second University of Naples, Nuovo Policlinico (Edificio 9C), Via Pansini 5, 80131, Naples, Italy.
Isdin (Spain) · ESUniversitat de Barcelona · ESUniversity of Campania "Luigi Vanvitelli" · ITValencia Catholic University Saint Vincent Martyr · ES

Funding

Genetic Epidermiology of MelanomaR01CA083115 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BISHOP, DAVID TIMOTHY, ELDER, DAVID ERIC · 2001 to 2017
$13.0M
NCI NIH HHS R01 CA083115
6 · The paper itself

Abstract

Actinic keratosis (AK) is a common pathology that afflicts sun-exposed areas of the skin. It predominantly affects older and fair-skinned individuals suggesting an accumulative damage attributable to chronic sun exposure. The prevalence of AK has risen in the past decades and is expected to continue to rise. Apart from visible hyperkeratotic, hyperplastic lesions, AK is also associated with the presence of subclinical lesions adjacent to tumor tissue, which has led to the use of the concept "cancerization field". Although lesion- and field-targeting treatments are currently available, many are associated with local side effects and recurrence of new lesions. This review provides information on AK pathophysiology and treatment options and summarizes the available clinical evidence supporting the use of Eryfotona AK-NMSC, a film-forming medical device with SPF 100+ containing the DNA repair enzyme photolyase, for managing AK, based on the analysis of the results of 228 patients treated with the product.

fundingISDIN funded the Article Processing Charges.

Indexed as

Actinic keratosisConfocal microscopyDermoscopyField cancerizationMelanomaOCTPhotolyaseSkin cancerSunscreenUVB

Identifiers

PMID30968311
PMCPMC6522584
OpenAlexW2938620764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.